Correction of liver changes caused by alcohol rates with probiotics

Authors

1 Abai Kazakh National Pedagogical University, Faculty of Natural Sciences and Geography, Almaty, Kazakhstan

2 Karaganda Buketov University, Karaganda, Kazakhstan

3 Department of Physiology, NP JSC “Karaganda Medical University”, Karaganda, Kazakhstan

4 Warsaw University of Life Sciences, Biochemistry and Microbiology Department, Institute of Biology. Warsaw, Poland

5 Institute of Genetics and Physiology, MS MHES RK, Almaty, Kazakhstan

6 Department of Chemistry and Biology, Faculty of Pedagogical and Natural Sciences, Zh. Tashenev university, Shymkent, Kazakhstan

10.22124/cjes.2024.8123

Abstract

There is evidence of the beneficial effects of probiotics in fatty liver cases. This study aims to evaluate the effects of probiotic intake on several metabolic factors in people with fatty liver. Eighty patients with fatty liver with a body mass index above 25 were divided into three groups: the control group, the alcohol group, and the probiotic group. After 45 days, fasting blood samples, physical changes, and dietary intakes were measured over the experiment. Statistical analysis was performed with SPSS software, and variance analysis was done. Significant reduction in weight (4%) and BMI (5%) was observed (p-value less than 0.001). The percent changes in weight and BMI were at a rate of 4.8% compared to the control group. The waist circumference in both groups showed a significant difference after the intervention, with the probiotic group decreasing by 8% compared to the control group. The findings showed that probiotic treatment was beneficial in reducing the severity of liver damage, most likely through increasing beneficial bacteria and reducing inflammatory responses and oxidative stress, and led to weight loss and BMI.

Keywords

References

Bajaj, JS 2019, Alcohol, liver disease and the gut microbiota. Nature Reviews Gastroenterology & Hepatology, 16: 235-246.
Cesaro, C, Tiso, A, Del Prete, A, Cariello, R, Tuccillo, C, Cotticelli, G & Loguercio, C 2011, Gut microbiota and probiotics in chronic liver diseases. Digestive and Liver Disease, 43: 431-438.
Elshaghabee, FM, Rokana, N, Panwar, H, Heller, KJ & Schrezenmeir, J 2019, Probiotics for dietary management of non-alcoholic fatty liver disease. Environmental Chemistry Letters, 17: 1553-1563.
Fooladi, AAI, Hosseini, HM, Nourani, MR, Khani, S & Alavian, SM 2013, Probiotic as a novel treatment strategy against liver disease. Hepatitis Monthly, 13.
Forsyth, CB, Farhadi, A, Jakate, SM, Tang, Y, Shaikh, M & Keshavarzian, A 2009, Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol, 43: 163-172.
Fuenzalida, C, Dufeu, MS, Poniachik, J, Roblero, JP, Valenzuela Pérez, L & Beltrán, CJ 2021, Probiotics-based treatment as an integral approach for alcohol use disorder in alcoholic liver disease. Frontiers in Pharmacology, 12: 729950.
Gratz, SW, Mykkanen, H & El Nezami, HS 2010, Probiotics and gut health: a special focus on liver diseases. World Journal of Gastroenterology: WJG, 16: 403.
Gu, Z, Liu, Y, Hu, S, You, Y, Jiaqi, W, Li, W & Wang, Y 2019, Probiotics for alleviating alcoholic liver injury. Gastroenterology Research and Practice, 2019: 9097276.
Gu, Z, Wu, Y, Wang, Y, Sun, H, You, Y, Piao, C & Wang, Y 2020, Lactobacillus rhamnosus granules dose-dependently balance intestinal microbiome disorders and ameliorate chronic alcohol-induced liver injury. Journal of Medicinal Food, 23: 114-124.
Hong, Meegun, Kim, SW, Han, SH, Kim, DJ, Suk, KT, Kim, YS, Kim, MJ, Kim, MY, Baik, SK & Ham, YL 2015, "Probiotics (Lactobacillus rhamnosus R0011 and L. acidophilus R0052) reduce the expression of toll-like receptor 4 in mice with alcoholic liver disease." PLoS One, 10: e0117451.
Hsieh, PS, Chen, CW, Kuo, YW & Ho, HH 2021, Lactobacillus spp. reduces ethanol‑induced liver oxidative stress and inflammation in a mouse model of alcoholic steatohepatitis. Experimental and Therapeutic Medicine, 21: 1.
Huang, H, Lin, Z, Zeng, Y, Lin, X & Zhang, Y 2019, Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model. Experimental and Therapeutic Medicine, 18: 4733-4739.
Jeong, JJ, Park, HJ, Cha, MG, Park, E, Won, SM, Ganesan, R & Suk, KT 2022, The Lactobacillus as a probiotic: focusing on liver diseases. Microorganisms, 10: 288.
Jeong, JJ, Park, HJ, Cha, MG, Park, E, Won, SM, Ganesan, R & Suk, KT 2022, The Lactobacillus as a probiotic: Focusing on liver diseases. Microorganisms, 10: 288.
Kim, J, Ahn, SW, Kim, JY, Whon, TW, Lim, SK, Ryu, BH & Lee, SH 2022, Probiotic Lactobacilli ameliorate alcohol-induced hepatic damage via gut microbial alteration. Frontiers in Microbiology, 13: 869250.
Kirpich, IA & McClain, CJ 2012, Probiotics in the treatment of the liver diseases. Journal of the American College of Nutrition, 31: 14-23.
Kirpich, IA, Solovieva, NV, Leikhter, SN, Shidakova, NA, Lebedeva, OV, Sidorov, PI & Cave, M 2008, Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: A pilot study. Alcohol, 42: 675-682.
Lata, J, Jurankova, J, Kopacova, M & Vitek, P 2011, Probiotics in hepatology. World journal of Gastroenterology: WJG, 17: 2890.
Li, F, Duan, K, Wang, C, McClain, C & Feng, W 2016, Probiotics and alcoholic liver disease: treatment and potential mechanisms. Gastroenterology Research and Practice, 2016: 5491465.
Manzhalii, E, Virchenko, O, Falalyeyeva, T, Beregova, T & Stremmel, W 2017, Treatment efficacy of a probiotic preparation for non‐alcoholic steatohepatitis: a pilot trial. Journal of Digestive Diseases, 18: 698-703.
Marlicz, W, Wunsch, E, Mydlowska, M, Milkiewicz, M, Serwin, K, Mularczyk, M & Raszeja-Wyszomirska, J 2016, The effect of short term treatment with probiotic VSL# 3 on various clinical and biochemical parameters in patients with liver cirrhosis. Journal of Physiology and Pharmacology, 67: 867-877.
Moulaei, K, Afrash, MR, Parvin, M, Shadnia, S, Rahimi, M, Mostafazadeh, B & Hosseini, SM 2024, Explainable artificial intelligence (XAI) for predicting the need for intubation in methanol-poisoned patients: a study comparing deep and machine learning models. Scientific Reports, 14: 15751.
Ram, M, Afrash, MR, Moulaei, K, Parvin, M, Esmaeeli, E, Karbasi, Z & Sabahi, A 2024, Application of artificial intelligence in chronic myeloid leukemia (CML) disease prediction and management: A scoping review. BMC Cancer, 24: 1026.
Stadlbauer, V, Mookerjee, RP, Hodges, S, Wright, GA, Davies, NA & Jalan, R 2008, Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. Journal of Hepatology, 48: 945-951.
Sun, X, Shi, J, Kong, L, Shen, Q, Zeng, X, Wu, Z & Pan, D 2022, Recent insights into the hepatoprotective effects of lactic acid bacteria in alcoholic liver disease. Trends in Food Science & Technology, 125: 91-99.
Sung, H, Kim, SW, Hong, M & Suk, KT 2016, Microbiota-based treatments in alcoholic liver disease. World Journal of Gastroenterology, 22: 6673.
Tian, F, Chi, F, Wang, G, Liu, X, Zhang, Q, Chen, Y & Chen, W 2015, Lactobacillus rhamnosus CCFM1107 treatment ameliorates alcohol-induced liver injury in a mouse model of chronic alcohol feeding. Journal of Microbiology, 53: 856-863.
Vassallo, G, Mirijello, A, Ferrulli, A, Antonelli, M, Landolfi, R, Gasbarrini, A & Addolorato, G 2015, alcohol and gut microbiota‐the possible role of gut microbiota modulation in the treatment of alcoholic liver disease. Alimentary Pharmacology & Therapeutics, 41: 917-927.
Vatsalya, V, Feng, W, Kong, M, Hu, H, Szabo, G, McCullough, A & McClain, CJ 2023, The beneficial effects of lactobacillus GG therapy on liver and drinking assessments in patients with moderate alcohol-associated hepatitis. Official Journal of the American College of Gatroenterology| ACG, 118: 1457-1460.
Vidya Bernhardt, G, Shivappa, PR, Pinto, J, Ks, R, Ramakrishna Pillai, J, Kumar Srinivasamurthy, S & Paul Samuel, V 2024, Probiotics—role in alleviating the impact of alcohol liver disease and alcohol deaddiction: a systematic review. Frontiers in Nutrition, 11: 1372755.
Wang, Y, Liu, Y, Kirpich, I, Ma, Z, Wang, C, Zhang, M & Feng, W 2013, Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury. The Journal of Nutritional Biochemistry, 24: 1609-1615.
Wang, Y, Liu, Y, Sidhu, A, Ma, Z, McClain, C & Feng, W 2012, Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. American Journal of Physiology-Gastrointestinal and Liver Physiology, 303: G32-G41.
Caspian Journal of Environmental Sciences
Volume 22, Issue 4
October 2024
Pages 993-998

Files

Share

How to cite

Statistics